Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 10:51:41 2026-07-30 am EDT			5-day change	1st Jan Change
472.63 ^USD	-2.21%		-0.34%	+4.00%

Jul. 29	Abcellera Biologics Inc. Announces Collaboration with Vertex Pharmaceuticals Incorporated to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions	CI
Jul. 21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	122,672	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	6.65%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	108,929	104,060	99,031
Change	-	31.13%	47.8%	4.23%	11.09%	0.47%	-4.47%	-4.83%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	27.6x	24.4x	19.9x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.54x	4.59x	3.86x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.8x	0.9x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.4x	8.54x	7.58x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.35x	7.25x	6.12x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.8x	15.6x	12.9x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19.7x	16.4x	13.1x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	22.3x	20.5x	16.7x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.49%	4.88%	5.97%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.5	19.85	24.34
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,051	14,357	16,189
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,789	6,650	7,648
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,532	6,347	7,536
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,508	5,124	6,248
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-13,743	-18,611	-23,641
Reference price ²	219.60	288.78	406.89	402.70	453.36	483.33	483.33	483.33
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	27.62x	8.35x	18.82x	-.--%	123B
ELI LILLY AND COMPANY	35.93x	12.83x	26.95x	0.56%	1,079B
JOHNSON & JOHNSON	28.47x	6.51x	18.01x	2.02%	640B
ABBVIE INC.	33.14x	7.75x	15.92x	2.61%	465B
ROCHE HOLDING AG	20.04x	4.79x	11.87x	2.76%	353B
NOVARTIS AG	22.45x	5.8x	14.46x	2.76%	301B
ASTRAZENECA PLC	22.33x	4.59x	13.01x	1.91%	271B
NOVO NORDISK A/S	14.91x	5.52x	11.38x	3.36%	228B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.83x	5.73x	31.65x	2.48%	165B
Average	18.25x	6.85x	17.38x	2.11%	383.23B
Weighted average by Cap.	25.18x	8.06x	18.95x	1.87%